SCHEMBL4570427

SCHEMBL4570427

Cc1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)cc2)c2cccc3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 6/20 0.44
▸ CYP2A6 P11509 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ EGFR P00533 1/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ CRHR1 P34998 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16369085 1.00 SIGMAR1 (0.44) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL19763114 1.00 SIGMAR1 (0.44) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL2607224 1.00 SIGMAR1 (0.44) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL16386586 1.00 SIGMAR1 (0.44) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL12744267 0.98 SIGMAR1 (0.43) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL14018297 0.98 SIGMAR1 (0.43) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL14018315 0.98 SIGMAR1 (0.43) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL12744268 0.98 SIGMAR1 (0.43) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL22129835 0.98 SIGMAR1 (0.43) SIGMAR1CYP2A6ALDH1A1NPC1XBP1
SCHEMBL19763128 0.98 SIGMAR1 (0.43) SIGMAR1CYP2A6ALDH1A1NPC1XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3620497-B1 ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE COMPRISING THEREOF SAMSUNG ELECTRONICS CO LTD (KR) 2021-10-27 — — EP disclosed
US-9266906-B2 Copper(I) complexes for optoelectronic devices CYNORA GMBH (DE) 2016-02-23 — — US disclosed
US-20150340614-A1 BINUCLEAR METAL(I) COMPLEXES FOR OPTOELECTRONIC APPLICATIONS CYNORA GMBH (DE) 2015-11-26 — — US disclosed
US-9024026-B2 Copper (I) complexes for optoelectronic devices CYNORA GMBH (DE) 2015-05-05 — — US disclosed
US-20140326981-A1 HETEROLEPTIC COPPER COMPLEXES FOR OPTOELECTRONIC USES SAMSUNG DISPLAY CO., LTD. (KR) 2014-11-06 — — US disclosed
US-20140302230-A1 METHOD TO MAKE ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL Konica Minolta, Inc. (JP) 2014-10-09 — — US disclosed
US-20140235006-A1 COPPER(I) COMPLEXES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-21 — — US disclosed
US-20130150581-A1 COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2013-06-13 — — US disclosed
US-20120123073-A1 ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD OF MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2012-05-17 — — US disclosed
US-20090066238-A1 Electroluminescent materials grafted with charge transport moieties having graded ionization potential or electrophilic property and their application in light-emitting diodes NATIONAL TSING HUA UNIVERSITY (TW) 2009-03-12 — — US disclosed
US-20070155928-A1 Phosphorescent polymer compound and organic light emitting device using the same SHOWDA DENKO K.K. 2007-07-05 — — US disclosed
US-20070155928-A1 Phosphorescent polymer compound and organic light emitting device using the same SHOWDA DENKO K.K. 2007-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150340614-A1 BINUCLEAR METAL(I) COMPLEXES FOR OPTOELECTRONIC APPLICATIONS OCIAD2, OCIAD1, CRY2 SIGMAR1 1005/4885CYP2A6 3676/4885ALDH1A1 2048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback